Corvus Pharmaceuticals, Inc. (CRVS) DCF Valuation

Corvus Pharmaceuticals, Inc. (CRVS) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Corvus Pharmaceuticals, Inc. (CRVS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Corvus Pharmaceuticals, Inc. (CRVS) financial prospects like an expert! This (CRVS) DCF Calculator provides you with pre-filled financial data and total flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -48.9 -5.4 -42.8 -40.9 -26.9 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .7 .6 .5 .4 .2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -49.6 -6.0 -43.2 -41.3 -27.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 78.0 44.3 69.5 42.3 27.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .3 .1 .5 .6 .1
Account Receivables, % 100 100 100 100 100
Inventories -.8 -.5 -.7 -.7 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.4 3.5 1.6 2.0 1.5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 .0 -.3 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -46.5 -4.8 -38.2 -50.0 -27.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -42.8 -3.3 -39.9 -49.6 -27.5 -1.5 .0 .0 .0 .0
WACC, % 9.92 9.83 9.88 9.96 9.96 9.91 9.91 9.91 9.91 9.91
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -11
Equity Value 10
Diluted Shares Outstanding, MM 48
Equity Value Per Share 0.21

What You Will Get

  • Comprehensive CRVS Financials: Access to historical and projected data for precise valuation.
  • Customizable Variables: Adjust inputs like WACC, tax rates, revenue growth, and capital expenditures.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Testing: Evaluate various scenarios to assess Corvus Pharmaceuticals' future performance.
  • User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.

Key Features

  • Comprehensive Financial Data: Gain access to precise pre-loaded historical performance and future forecasts for Corvus Pharmaceuticals, Inc. (CRVS).
  • Adjustable Forecast Parameters: Modify highlighted cells for variables such as discount rates, growth expectations, and profit margins.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: Utilize clear, visually appealing charts and summaries to interpret your valuation findings.
  • Designed for All Skill Levels: A user-friendly format tailored for investors, CFOs, and consultants alike.

How It Works

  • Step 1: Download the prebuilt Excel template with Corvus Pharmaceuticals, Inc. (CRVS) data included.
  • Step 2: Explore the pre-filled sheets and understand the key metrics specific to Corvus Pharmaceuticals.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Corvus Pharmaceuticals' intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose This Calculator for Corvus Pharmaceuticals (CRVS)?

  • User-Friendly Interface: Tailored for both novice and seasoned users.
  • Customizable Inputs: Modify parameters effortlessly to suit your analysis needs.
  • Real-Time Valuation: Observe immediate updates to Corvus’s valuation with input adjustments.
  • Preloaded Data: Comes equipped with Corvus’s actual financial metrics for swift evaluations.
  • Relied Upon by Experts: A go-to tool for investors and analysts seeking to make data-driven choices.

Who Should Use This Product?

  • Investors: Accurately estimate Corvus Pharmaceuticals’ fair value before making investment decisions.
  • CFOs: Leverage a professional-grade DCF model for financial reporting and analysis related to Corvus Pharmaceuticals (CRVS).
  • Consultants: Quickly adapt the template for valuation reports tailored to Corvus Pharmaceuticals (CRVS) clients.
  • Entrepreneurs: Gain insights into financial modeling techniques utilized by leading biotech firms like Corvus Pharmaceuticals (CRVS).
  • Educators: Use it as a teaching tool to illustrate valuation methodologies relevant to the biotech sector, including Corvus Pharmaceuticals (CRVS).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Corvus Pharmaceuticals historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Corvus Pharmaceuticals, Inc. (CRVS).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.